Sungwhan An,
CEO,
Genomictree Inc
Sungwhan An is the founder and Chief Executive Officer of Genomictree, Inc. Molecular diagnostic company based in South Korea since 2000. He also had been worked in Cancer Metastasis Research Center of Yonsei University, College of Medicine, South Korea as an assistant professor from 2003 to 2009. He earned his Ph.D. in the field of molecular virology at the University of Texas at Austin before he went through a postdoctoral training course from 1999 to 2000 at Dr. Harry Greenberg’s lab in the Stanford University School of Medicine where he had been involved in translational research to investigate host cell gene expression profiles when Hepatitis Virus C infected using DNA microarray tool. Current his interest at Genomictree is to discover and develop new DNA methylation biomarkers for the detection of cancers in minimum or non-invasively accessible specimens. In addition, he has established the open platform technique of multiplex assay for the multiple markers and been focusing to extend its utility into the molecular diagnostics for cancer mutations and infectious agents
|
|
|